Keywords: medimmune, numax, sees, good, ph, i/ii, drugmaker

MedImmune's Numax sees good Ph I/II

Article | 30 May 2005

Print This

US drugmaker MedImmune says that a Phase I/II study demonstrating that Numax, its humanized monoclonal antibody currently being developed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in